A new study from the University of Chicago taps an ingredient most often used in the lithium-ion batteries that power our ...
In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...
CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a “standalone CDMO ...
New York State's biomedical research sector, a significant contributor to the state's economy, faces increasing competition for funding and talent. The NYFIRST program, designed to attract and retain ...
As of Tuesday, Impact BioMedical Inc.’s IBO share price has dipped by 8.13%, which has investors questioning if this is right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results